Antigout Agents

Manage uric acid levels and treat gout effectively with high-quality antigout raw materials. Explore a range of antigout chemical products with CAS NO., property information, and SDS. Source raw materials from certified suppliers to support pharmaceutical formulations, clinical treatments, and research in gout management.

Isoniazid

(54-85-3)

For the treatment of all forms of tuberculosis in which organisms are susceptible.

Isoniazid SDS

Pharmaceutical Grade / 99%

Xi'an Honest BioEngr Co.,Ltd.
Pharmaceutical Grade / 99%

Shandong Airuike Chemical Co., Ltd.
Pharmaceutical Grade / 99%

HNB Biotech
Pharmaceutical Grade / 99%

Greenbo Biochem

Request for quotation , get quotes from more suppliers.

Antigout Agents Intermediates are some key chemical raw materials or products in the synthesis process of anti-gout drugs. You can easily find high-quality new intermediates, products and their manufacturers or suppliers on ECHEMI. ECHEMI will continue to track the research and development of new products on anti-gout medicine.

More Information

Antigout agents are substances used to prevent or treat gout, a condition caused by elevated uric acid levels leading to joint inflammation and pain. These agents are widely applied in pharmaceutical formulations, hospital treatments, and research focused on hyperuricemia and metabolic disorders.

Key mechanisms of action for antigout agents include:
• Xanthine oxidase inhibitors – Reduce uric acid production by inhibiting the enzyme xanthine oxidase.
• Uricosuric agents – Increase renal excretion of uric acid to lower serum levels.
• Anti-inflammatory agents – Reduce inflammation and pain associated with acute gout attacks.
• Recombinant uricase – Convert uric acid into more soluble compounds for easier excretion.

Factors to consider when selecting antigout raw materials:
• Type of gout – acute attack vs. chronic management.
• Patient health status – kidney function, comorbidities, and drug tolerability.
• Formulation requirements – solubility, stability, and compatibility for tablets, capsules, or injectables.
• Regulatory compliance – adherence to pharmaceutical standards and clinical guidelines.

Common antigout raw materials include allopurinol, febuxostat, probenecid, colchicine, and pegloticase. They are typically supplied in powder or crystalline forms suitable for oral or injectable formulations. These agents are essential for clinical therapy, pharmaceutical development, and research on gout and hyperuricemia.

Frequently Asked Questions

What are Antigout Agents and how do they work?

Antigout Agents are medications used to treat or prevent gout, a form of inflammatory arthritis caused by elevated levels of uric acid in the blood. These agents work through different mechanisms: some reduce uric acid production (e.g., xanthine oxidase inhibitors like allopurinol), while others increase uric acid excretion (e.g., uricosurics like probenecid). Understanding their mode of action helps healthcare providers choose the most appropriate therapy based on patient-specific factors.

What are the common types of Antigout Agents available in the pharmaceutical market?

The most commonly used Antigout Agents fall into three main categories:1. Xanthine oxidase inhibitors (e.g., allopurinol, febuxostat) that lower uric acid production.2. Uricosuric agents (e.g., probenecid, lesinurad) that enhance renal excretion of uric acid.3. Anti-inflammatory drugs (e.g., colchicine, NSAIDs, corticosteroids) used for acute gout flare management.Each class serves distinct therapeutic purposes and is selected based on disease stage, comorbidities, and patient response.

How do I choose a reliable supplier for Antigout Agent APIs or intermediates?

Selecting a reliable supplier for Antigout Agent active pharmaceutical ingredients (APIs) or intermediates requires evaluating several key criteria:1. Regulatory compliance with GMP, FDA, EMA, or other relevant standards.2. Robust quality control systems, including analytical testing and documentation.3. Proven experience in manufacturing specific antigout compounds like allopurinol or febuxostat.4. Scalable production capacity and consistent supply chain reliability.5. Technical support and regulatory filing assistance (e.g., DMF availability).These factors ensure product safety, efficacy, and regulatory approval readiness.

Are there any emerging trends in the development of new Antigout Agents?

Yes, recent advancements in Antigout Agent development focus on improving efficacy and reducing side effects. Notable trends include:1. Novel urate-lowering therapies targeting URAT1 or other transporters with higher selectivity.2. Dual-action molecules combining anti-inflammatory and uric acid-lowering properties.3. Use of biologics and enzyme-based treatments (e.g., pegloticase) for refractory gout.4. Personalized medicine approaches based on genetic markers affecting uric acid metabolism.These innovations aim to address unmet needs in chronic gout management and improve long-term patient outcomes.

Browse more categories

Smoothing Inhibitors Biological Response Modifiers Biochemical Reagents Herbicides Plant Growth Regulators Flame Retardants Steroids Hair Waving or Straightening Abrasive



Feedback & Suggestions

Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.